Stay updated on Depemokimab in Severe Asthma Clinical Trial
Sign up to get notified when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.

Latest updates to the Depemokimab in Severe Asthma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRecruitment status is now shown as 'No longer looking for participants'. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading was standardized, with the Revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check19 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing v3.5.4, indicating a new version of the study record. This update appears to be a metadata/backend revision rather than a change to the study details shown.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page’s revision number has been updated from v3.5.3 to v3.5.4, reflecting a small update to the page’s documentation/versioning.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page’s footer was updated to reflect a newer ClinicalTrials.gov revision version (v3.5.3). A previously listed journal publication citation was removed from the Publications section.SummaryDifference0.0%

- Check77 days agoChange DetectedIQVIA Pty Ltd was added to the Collaborators and Investigators section and Iqvia Pty Ltd was removed, reflecting capitalization normalization of the organization name.SummaryDifference0.0%

- Check84 days agoChange DetectedPublications section updated with a new reference: Early and Sustained Efficacy of Depemokimab in Type 2 Asthma: A Pooled Analysis of the SWIFT-1/-2 Studies.SummaryDifference0.0%

Stay in the know with updates to Depemokimab in Severe Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Depemokimab in Severe Asthma Clinical Trial page.